Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-17), Elevance Health's 14-Day RSI is 38.17.
The industry rank for Elevance Health's 14-Day RSI or its related term are showing as below:
ELV's 14-Day RSI is ranked better than 94.44% of 18
companies
in the Healthcare Plans industry
Industry Median: 49.565
vs ELV: 38.17
Elevance Health (NYSE:ELV) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Elevance Health 14-Day RSI Related Terms
ELV vs CI, HUM, CVS: 14-Day RSI Comparison
For the Healthcare Plans subindustry, Elevance Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health 14-Day RSI vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Elevance Health's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (ELV) has a 14-Day RSI of 38.17 as of Jul. 17, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Elevance Health and its competitors. According to the industry distribution chart, Elevance Health ranks #1 out of 18 companies in the Healthcare Plans industry, placing it in the top 5.6%.
Is Elevance Health's 14-Day RSI too high?
Elevance Health's current 14-Day RSI is 38.17. The Healthcare Plans industry median 14-Day RSI is 49.57. Elevance Health's value of 38.17 is 23% below this industry median. Based on the distribution chart, Elevance Health ranks #1 out of 18 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Elevance Health has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's 14-Day RSI compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #1 out of 18 companies for 14-Day RSI. This places Elevance Health in the top 6% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.57. Elevance Health's value of 38.17 is 23% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Plans company?
The median 14-Day RSI among Healthcare Plans companies is 49.57, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current 14-Day RSI of 38.17 is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median 14-Day RSI is 49.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current 14-Day RSI is 38.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is $490.84, compared to a current price of $373.11 — trading 24% below its estimated fair value. The current 14-Day RSI is 38.17 and 23% below the Healthcare Plans industry median of 49.57. Elevance Health's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Elevance Health (ELV), the current 14-Day RSI is 38.17 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of $373.11 is trading 24% below its estimated GF Value™ of $490.84.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for ELV:
14-Day RSI: 38.17
GF Value™: $490.84 vs. price of $373.11 (24% below fair value)
Industry Position: 23% below the Healthcare Plans median (#1 of 18)
No single metric tells the full story. See the ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
89GF Score
Get the complete analysis for ELV
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELV has been successfully added to your 
